Related Experiment Video
Updated: Jan 9, 2026

08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.5K
Characterizing Paratesticular Neoplasms in Proteus Syndrome
Andres Matoso1,2,3, Russell Vang1,4, Deyin Xing1,2
1Departments of Pathology.
The American Journal of Surgical Pathology
|December 10, 2025
Summary
Proteus syndrome patients have a high risk of paratesticular tumors, often Müllerian in origin and linked to the AKT1 gene variant. These tumors can recur and show atypical histology, requiring careful monitoring.
Area of Science:
- Genetics and Oncology
- Pathology
- Endocrinology
Background:
- Proteus syndrome is a rare mosaic overgrowth disorder linked to somatic AKT1 variants.
- It increases the risk of benign and malignant neoplasms, including paratesticular masses.
- Paratesticular tumors in Proteus syndrome are poorly understood.
Purpose of the Study:
- To document the clinicopathologic features of paratesticular tumors in males with Proteus syndrome.
- To investigate the histological spectrum and immunohistochemical profile of these tumors.
- To determine the association with the AKT1 gene variant.
Main Methods:
- Longitudinal natural history study of 64 males with genetically confirmed Proteus syndrome.
- Surgical and histopathological review of 12 paratesticular masses.
- Immunohistochemistry and exome sequencing of tumor samples.
Main Results:
- 19% of males developed paratesticular masses, typically unilateral, small, and slow-growing.
- Tumors showed diverse histology, frequently Müllerian-type (papillary cystadenomas, adenocarcinomas, Brenner tumor).
- Consistent PAX8, WT1, ER, and PR expression supported Müllerian lineage; all sequenced tumors harbored the AKT1 c.49G>A variant.
Conclusions:
- Paratesticular tumors are a significant component of the Proteus syndrome phenotype.
- These tumors exhibit Müllerian differentiation and are associated with the AKT1 c.49G>A variant.
- Recurrence and atypical histology highlight the need for vigilant follow-up.
Related Concept Videos
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K

